Search results

Photo of Prostate cancer cells under microscope, pink and purple tones.

Prostate Cancer Nexus

28/10/25

Transcript: Advances in prostate cancer at ESMO 2025

Read a transcript of Alicia Morgans sharing practice-changing advances in prostate cancer, direct from ESMO 2025.

Guideline

01/10/25

EACS Guidelines version 13.0

The 2025 EACS Guidelines provide updated, evidence-based recommendations for HIV care across Europe, covering prevention, treatment, co-morbidities, and access disparities. Designed for clinicians, the guideline supports decision-making in diverse healthcare settings.

Source: European AIDS Clinical Society (EACS)

Guideline

08/05/24

Management of ALL in adults: 2024 ELN recommendations from a European expert panel

This 2024 ELN guideline addresses the clinical management of adult acute lymphoblastic leukaemia (ALL), from diagnosis to aftercare. It includes recommendations on immunotherapies, MRD-guided treatment decisions, subgroup-specific strategies, and supportive care for long-term outcomes.

Source: European LeukemiaNet (ELN)

Prostate Cancer Nexus

30/10/25

Transcript: Neal Shore on the EMBARK trial

Read a transcript of Neal Shore discussing the final overall survival analysis of patients with mCRPC in the EMBARK trial, presented at ESMO 2025.

Guideline

01/02/25

AGA Clinical Practice Guideline on the prevention and treatment of hepatitis B birus reactivation in at-risk individuals

Hepatitis B virus reactivation (HBVr) can occur in patients exposed to immunosuppressive therapies. This AGA guideline update provides evidence-based recommendations for antiviral prophylaxis and monitoring strategies based on individual risk levels.

Source: American Gastroenterological Association (AGA)

Guideline

01/08/25

EASL Clinical Practice Guidelines on the management of hepatitis B virus infection

Chronic hepatitis B affects over 250 million people globally and remains a major cause of cirrhosis and liver cancer. These updated EASL guidelines offer evidence-based recommendations across diagnostics, treatment, prevention, and special populations to support HBV elimination goals.

Source: European Association for the Study of the Liver (EASL)

Guideline

10/12/22

BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 (2025 interim update)

The BHIVA guideline provides evidence-based recommendations for initiating, switching, and optimizing antiretroviral therapy (ART) in adults with HIV-1. It addresses virological failure, toxicity management, and tailored approaches for specific populations, supporting clinical decision-making.